ONVO实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (2 May 2024 @ 04:00):

Stats
今日成交量	381 492
平均成交量	1.04M
市值	10.61M
EPS	$0 ( 2024-02-08 )
下一个收益日期	( $-0.420 ) 2024-07-11
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.430
ATR14	$0.00200 (0.21%)

Insider Trading

Date	Person	Action	Amount	type
2023-11-17	Stern Adam K	Buy	19 607	Common Stock
2023-11-17	Milhous Alison Tjosvold	Buy	19 607	Common Stock
2023-11-17	Cohen Douglas Jay	Buy	19 607	Common Stock
2023-11-17	Murphy Keith	Buy	19 607	Common Stock
2023-11-17	Gobel David	Buy	19 607	Common Stock

INSIDER POWER
81.26
Last 90 transactions
Buy: 3 116 580 \| Sell: 414 691

音量相关性

長: -0.02 (neutral)

短: 1.00 (very strong)

Signal:(36.797) Expect same movement, but be aware

Organovo Holdings Inc 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Organovo Holdings Inc 相关性 - 货币/商品

0.37
( neutral )

0.33
( neutral )

0.00
( neutral )

0.67
( moderate )

Organovo Holdings Inc 财务报表

Annual	2022
营收:	$370 000
毛利润:	$77 000.00 (20.81 %)
EPS:	$-1.980

FY	2022
营收:	$370 000
毛利润:	$77 000.00 (20.81 %)
EPS:	$-1.980

FY	2022
营收:	$1.50M
毛利润:	$1.50M (100.00 %)
EPS:	$-1.320

FY	2021
营收:	$0.00
毛利润:	$0.00 (0.00 %)
EPS:	$-2.44

Financial Reports:

No articles found.

Organovo Holdings Inc

Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive human liver tissue and ExVive human kidney tissue used for predictive preclinical testing of drug compounds. The company was incorporated in 2007 and is headquartered in Solana Beach, California.